title: PCSK9 inhibitors - clinical applications.
authors: Department of Endocrinology, Canberra Hospital.
authors: Robert
authors: R
authors: Schmidli
keywords: LDL cholesterol; alirocumab; bococizumab; evolocumab; ischaemic heart disease; proprotein convertase subtilisin/kexin type 9